ARDENT HEALTH INC (ARDT) Forecast, Price Target & Analyst Ratings

NYSE:ARDT • US03980N1072

Current stock price

9.91 USD
+0.47 (+4.98%)
At close:
10 USD
+0.09 (+0.91%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARDENT HEALTH INC (ARDT).

Forecast Snapshot

Consensus Price Target

Price Target
$13.04
+ 31.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
$0.19
Revenue Estimate
1.614B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.89%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.04
Upside
+ 31.54%
From current price of $9.91 to mean target of $13.04, Based on 19 analyst forecasts
Low
$8.89
Median
$13.26
High
$15.75

Price Target Revisions

1 Month
-6.78%
3 Months
-6.94%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for ARDT. The average price target is 13.04 USD. This implies a price increase of 31.54% is expected in the next year compared to the current price of 9.91.
The average price target has been revised downward by 6.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ARDT Current Analyst RatingARDT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ARDT Historical Analyst RatingsARDT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
77.89%
ARDT was analyzed by 19 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ARDT.
In the previous month the buy percentage consensus was at a similar level.
ARDT was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10RBC CapitalMaintains Outperform -> Outperform
2026-03-06Leerink PartnersMaintains Outperform -> Outperform
2026-01-20JP MorganMaintains Neutral -> Neutral
2025-12-18MizuhoMaintains Outperform -> Outperform
2025-12-18UBSMaintains Buy -> Buy
2025-11-24JP MorganMaintains Neutral -> Neutral
2025-11-18MizuhoMaintains Outperform -> Outperform
2025-11-18GuggenheimMaintains Buy -> Buy
2025-11-17KeybancDowngrade Overweight -> Sector Weight
2025-11-14RBC CapitalMaintains Outperform -> Outperform
2025-11-14Stephens & Co.Maintains Overweight -> Overweight
2025-11-14Truist SecuritiesMaintains Buy -> Buy
2025-11-14Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-13B of A SecuritiesMaintains Underperform -> Underperform
2025-10-14Goldman SachsInitiate Neutral
2025-09-10UBSInitiate Buy
2025-08-11JP MorganMaintains Neutral -> Neutral
2025-08-07KeybancMaintains Overweight -> Overweight
2025-07-16B of A SecuritiesDowngrade Neutral -> Underperform
2025-05-20Stephens & Co.Reiterate Overweight -> Overweight
2025-05-15RBC CapitalReiterate Outperform -> Outperform
2025-05-09GuggenheimMaintains Buy -> Buy
2025-04-09MizuhoMaintains Outperform -> Outperform
2025-04-09GuggenheimInitiate Buy
2025-04-01Stephens & Co.Reiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
$0.19
Revenue Estimate
1.614B
Revenue Q2Q
7.80%
EPS Q2Q
-35.04%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
0.37%
Revenue (3 Months)
-0.55%
EPS (1 Month)
4.53%
EPS (3 Months)
-21.59%

Next Earnings Summary

ARDT is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is 0.19 USD and the consensus revenue estimate is 1.61B USD.
The next earnings revenue estimate has been revised downward by 0.55% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
ARDT revenue by date.ARDT revenue by date.
5.409B
5.45%		5.966B
10.29%		6.324B
6.01%		6.698B
5.91%		7.007B
4.61%		7.334B
4.67%
EBITDA
YoY % growth
ARDT ebitda by date.ARDT ebitda by date.
356.685M
5.40%		552.05M
54.77%		481.287M
-12.82%		524.43M
8.96%		556.61M
6.14%		583.86M
4.90%
EBIT
YoY % growth
ARDT ebit by date.ARDT ebit by date.
215.843M
7.79%		405.762M
87.99%		325.584M
-19.76%		369.26M
13.41%		403.52M
9.28%		397.72M
-1.44%
Operating Margin
ARDT operating margin by date.ARDT operating margin by date.
3.99%6.80%5.15%5.51%5.76%5.42%
EPS
YoY % growth
ARDT eps by date.ARDT eps by date.
N/AN/A1.65
34.18%		1.13
-31.51%		1.23
9.28%		1.38
11.65%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.19
-35.04%		0.34
-34.48%		0.24
-54.72%		0.37
15.53%		0.21
12.40%		0.39
14.55%		0.23
-4.34%		0.40
7.21%		0.21
-3.18%		0.43
10.82%		0.21
-6.70%		0.40
0.96%
Revenue
Q2Q % growth		1.614B
7.80%		1.699B
3.27%		1.677B
6.36%		1.72B
7.16%		1.699B
5.27%		1.776B
4.53%		1.762B
5.07%		1.824B
6.05%		1.734B
2.06%		1.835B
3.32%		1.803B
2.33%		1.853B
1.59%
EBITDA
Q2Q % growth		109.94M
6.44%		138.8M
-34.77%		123.23M
-6.02%		154.14M
-40.82%		120.68M
9.77%		146.07M
5.24%		129.71M
5.26%		164.66M
6.82%		116.25M
-3.67%		162.47M
11.23%		120.91M
-6.78%		161.76M
-1.76%
EBIT
Q2Q % growth		73.171M
9.06%		99.316M
-27.65%		87.456M
431.39%		117.01M
11.70%		86.618M
18.38%		100.22M
0.91%		88.57M
1.27%		121.69M
4.00%		70.798M
-18.26%		86.537M
-13.65%		89.423M
0.96%		117.9M
-3.11%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ARDT Yearly Revenue VS EstimatesARDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ARDT Yearly EPS VS EstimatesARDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-5.81%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.23%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
20.72%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ARDENT HEALTH INC / ARDT Forecast FAQ

What do analysts expect the price target to be for ARDENT HEALTH INC (ARDT)?

19 analysts have analysed ARDT and the average price target is 13.04 USD. This implies a price increase of 31.54% is expected in the next year compared to the current price of 9.91.

Can you provide the upcoming earnings date for ARDENT HEALTH INC?

ARDENT HEALTH INC (ARDT) will report earnings on 2026-05-12.

What are the consensus estimates for ARDT stock next earnings?

The consensus EPS estimate for the next earnings of ARDENT HEALTH INC (ARDT) is 0.19 USD and the consensus revenue estimate is 1.61B USD.

Can you provide the analyst count for ARDENT HEALTH INC stock?

The number of analysts covering ARDENT HEALTH INC (ARDT) is 19.